Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 438, 913 (15 December 2005) | doi:10.1038/438913b; Published online 14 December 2005
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
- More Challenges
- Powered by:
nature jobs
3 Postdoctoral positions available
- Baylor College of Medicine
- Houston, Texas, USA
Postdoctoral Research Fellows
- Northwestern University
- Chicago, Illinois, United States
In brief
British biotechnology company Astex Therapeutics last week announced a deal with Swiss drug giant Novartis that is potentially worth US$500 million. Under the agreement, Novartis will pay $25 million to secure the global licensing rights to Astex's anticancer drug AT9311.
To read this story in full you will need to login or make a payment (see right).
